Entry Detail



General Information

Database ID:exR0000030
RNA Name:ABCA3
RNA Type:mRNA
Chromosome:chr16
Starnd:-
Coordinate:
Start Site(bp):2275881End Site(bp):2340746
External Links:ENSG00000167972



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ATG2B
chr14
96279195
96363341
-
BCAR1
chr16
75228181
75268053
-
LAMB2
chr3
49121114
49133118
-
HLA-F
chr6
29722775
29738528
+
NOC4L
chr12
132144457
132152473
+
HS3ST3A1
chr17
13494032
13601929
-
ASRGL1
chr11
62337448
62393412
+
HNRNPUL2-BSCL2
chr11
62690275
62727384
-
SIK3
chr11
116843402
117098437
-
MCMBP
chr10
119829404
119892556
-
CYB5R3
chr22
42617840
42649392
-
RPL11
chr1
23691742
23696835
+
KLHL21
chr1
6590724
6614607
-
PVRIG
chr7
100218241
100221490
+
ZNF219
chr14
21090077
21104722
-
PKM
chr15
72199029
72231822
-
HMGB2
chr4
173331376
173334432
-
DNAJC18
chr5
139408588
139444491
-
MT-ND4L
chrMT
10470
10766
+
CHTF18
chr16
788046
800737
+
CDH4
chr20
61252261
61940617
+
TSC2
chr16
2047967
2089491
+
CDCA2
chr8
25459199
25507911
+
TPRN
chr9
137191617
137204193
-
HLA-E
chr6
30489509
30494194
+
DCP2
chr5
112976702
113022195
+
FAM104A
chr17
73207353
73236753
-
BUB3
chr10
123154402
123170467
+
RFWD3
chr16
74621399
74666877
-
TUBB2A
chr6
3153666
3157544
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC022167.2
chr16
8848105
8860456
+
AC245014.3
chr1
145281116
145281462
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.